
FDA approves first twice-yearly injection that prevents HIV infection
Fox News
The FDA has approved Yetzugo, Gilead Sciences' twice-yearly injectable HIV prevention treatment, which showed nearly 100% effectiveness in clinical trials.
Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
"This is a historic day in the decades-long fight against HIV," said Daniel O’Day, chairman and CEO of California-based Gilead Sciences, in a press release.
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












